Tolentino, Norviluz D.

HRN: 25 43 58  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/27/2024
01/02/2025
IV
4.5gm
Q8
Malignant Pleural Eff
Waiting Final Action 
12/28/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
12/28/2024
01/03/2025
IV
500 Mg
OD
Malignant Pleural Effusion
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: